Mr. Itzhak Medan, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 151 Carol Ln, Richboro, PA 18954 Phone: 443-676-2585 |
News Archive
Confluent Surgical, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the DuraSeal Dural Sealant System as the first and only product indicated as an adjunct to sutured dural repair during cranial surgery to achieve watertight closure. The FDA has approved the DuraSeal Sealant with a condition to conduct a post-approval study.
The 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session today entitled "The Prevention of Heart Failure." The session is being presented by HFSA and the American Heart Association.
Using a new form of brain imaging known as diffusion tensor imaging (DTI), researchers in the Center for Cognitive Brain Imaging at Carnegie Mellon University have discovered that the so-called white matter in the brains of people with autism has lower structural integrity than in the brains of normal individuals.
Applied NeuroSolutions, Inc., a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease ("AD"), today announced that Eli Lilly and Company has agreed to a one-year renewal of its drug discovery collaboration. Lilly will pay $250,000 to Applied NeuroSolutions for the one-year collaboration renewal.
ConforMIS has received 510(k) clearance from the U.S. Food and Drug Administration to commercially market its iTotalĀ® CR Knee Replacement System. The iTotal CR is the only true patient-specific system available for patients who would traditionally receive a standard total knee replacement (TKR).
› Verified 2 days ago